RenovoRx, Inc.

RNXT | NASDAQ | 4 Followers
$1.35 +3.05% $0.04
Follow
Loading...

Profile

RenovoRx, Inc. (RNXT) is an American biotechnology company focused on developing innovative therapies for the treatment of hard-to-treat cancers. The company is developing advanced targeted treatment technologies that enable the direct delivery of chemotherapy to tumors with minimal impact on surrounding healthy tissues. The company's flagship product is the RenovoTAMP™ system, designed to improve the efficacy and reduce the side effects of cancer treatment. RenovoRx aims to provide new treatment options for patients with limited therapeutic alternatives. RenovoRx, Inc. (RNXT) shares could be an interesting choice for investors looking for opportunities in the biotechnology sector and innovative treatment technologies.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade